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Endocrine differentiation in the early embryonic pancreas is regulated by Notch signaling. Activated Notch signaling maintains pancreatic
progenitor cells in an undifferentiated state, whereas suppression of Notch leads to endocrine cell differentiation. Yet it is not known what
mechanism is employed to inactivate Notch in a correct number of precursor cells to balance progenitor proliferation and differentiation. We report
that an established Notch modifier, Manic Fringe (Mfng), is expressed in the putative endocrine progenitors, but not in exocrine pancreatic tissues,
during early islet differentiation. Using chicken embryonic endoderm as an assaying system, we found that ectopicMfng expression is sufficient to
induce endodermal cells to differentiate towards an endocrine fate. This endocrine-inducing activity depends on inactivation of Notch.
Furthermore, ectopic Mfng expression induces the expression of basic helix–loop–helix gene, Ngn3, and two zinc finger genes, cMyt1 and cMyt3.
These results suggest that Mfng-mediated repression of Notch signaling could serve as a trigger for endocrine islet differentiation.
© 2006 Elsevier Inc. All rights reserved.Keywords: Notch; Manic Fringe; Myt1; Islet; Pancreas; Ngn3Introduction
The vertebrate pancreas arises from two buds located in the
dorsal and ventral sides of the gut tube (Slack, 1995). Starting
from embryonic day 9.5 (E9.5) in mouse, the epithelial cells
within these buds expand and differentiate to give rise to the
three major lineages of the pancreas—endocrine islets,
exocrine acini, and pancreatic ducts. Islets contain four major
cell types – α, β, δ, and PP cells – that secrete glucagon,
insulin, somatostatin (SS), and pancreatic polypeptide (PP),
respectively (Melloul, 2004; Hill, 2005), as well as infrequent
cell types that produce other hormones (Wierup et al., 2002).
Because loss of insulin production results in diabetes, islet
differentiation has been a subject of intensive studies.
The interactions between a host of transcription factors and
various signaling molecules, including TGFβ, FGF, hedge-⁎ Corresponding author. Fax: +1 615 936 5673.
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doi:10.1016/j.ydbio.2006.04.456hog, Notch, and Wnt, have been shown to play roles in
endocrine islet formation (Edlund, 1999, 2001; Jensen, 2004;
Kim and Hebrok, 2001; Kim and MacDonald, 2002; Kume,
2005; Pedersen, 2005; Sander and German, 1997; St-Onge et
al., 1999; Wilson et al., 2003). Among these interacting
molecules, the Notch-Ngn3 cascade is a key switch for islet
differentiation (Apelqvist et al., 1999). Active Notch signaling
suppresses Ngn3 expression and pancreatic differentiation
(Hald et al., 2003; Murtaugh et al., 2003). Suppression of
Notch signaling up-regulates Ngn3 expression and initiates
islet differentiation (Apelqvist et al., 1999; Jensen et al.,
2000b). Loss of Ngn3 function completely blocks endocrine
differentiation (Gradwohl et al., 2000), whereas ectopic Ngn3
expression induces precocious endocrine formation (Apelqvist
et al., 1999; Schwitzgebel et al., 2000). Several growth
factors that regulate islet development modify Ngn3 expres-
sion (Harmon et al., 2004; Hart et al., 2003; Norgaard et al.,
2003), and Ngn3 controls the expression of such transcription
factors as Nkx2.2, Nkx6.1, NeuroD1, Pax4, and Pax6, each of
which is essential for islet maturation (Ahlgren et al., 1997;
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et al., 1999; Naya et al., 1997; Sander et al., 2000; Sosa-
Pineda et al., 1997; St-Onge et al., 1997; Sussel et al., 1998).
The Notch pathway is active in most, if not all, early
pancreatic progenitor cells (Apelqvist et al., 1999; Esni et al.,
2004; Hald et al., 2003; Lammert et al., 2000). Thus, selective
suppression of Notch activity is likely a major determinant for
endocrine differentiation. Many ways are known to regulate
Notch activity. One mechanism involves Notch glycosylation
(Blair, 2000; Haines and Irvine, 2003). In Drosophila, β-1,3 N-
acetylglucosaminyltransferase, encoded by Fringe (Fng),
extends the sugar residues on the Notch receptor. This
modification potentiates Notch activation by Delta, but
attenuates signaling by Serrate to regulate wing margin
formation (Hukriede et al., 1997; Irvine and Wieschaus, 1994).
Mammals have three Fng paralogs: Lunatic Fringe (Lfng),
Manic Fringe (Mfng), and Radical Fringe (Rfng) (Johnston et
al., 1997). In tissue culture, these Fngs enhance or inhibit Notch
signaling in a Notch-ligand type-specific manner. For example,
Lfng and Mfng potentiate Delta1–Notch1 signal but inhibit
Jagged/Serrrate1–Notch 1 signal (Hicks et al., 2000; Yang et al.,
2005). Lfng and Mfng inhibit Jagged/Serrate1–Notch2 activa-
tion (Hicks et al., 2000), but have no effect on Delta1Notch 2
signaling (Shimizu et al., 2001). In loss of function studies, Lfng
mutant mice display defects in somitogenesis, rostral–caudal
patterning (Evrard et al., 1998), and meiotic maturation (Hahn et
al., 2005). Rfng mutant mice have no detectable defects (Zhang
et al., 2002). Loss ofMfng function has not been reported. Thus,
whether genetic redundancy exists for these family members and
whether these molecules modify Notch activity in mouse as in
tissue culture remain unclear.
Besides Ngn3, a zinc finger protein, Myt1, also induces
endocrine differentiation (Gu et al., 2004). Evidence for a
Notch, Ngn3, and Myt1 regulatory pathway comes from a study
of Xenopus neuronal development. In this system, repression of
Notch signaling activates xNgn1 and xMyt1 expression, and
xNgn1 induces xMyt1 expression as well to lead to neural
differentiation (Bellefroid et al., 1996). Because endocrine islet
development shares many mechanisms with neural develop-
ment, Myt1 may also mediates Notch signaling in the process of
endocrine differentiation.
Here, we report that Mfng expression in embryonic
endoderm activates the differentiation of all four major
pancreatic islet cell types. This endocrine induction coincides
with the activation of Ngn3 and Myt1 transcription. These
results highlight the possible roles of the Fng molecules in
endocrine islet differentiation.
Material and methods
DNA constructs
The pCIG vector that carries a CMV-βactin promoter is utilized to drive
ectopic gene expression (Niwa et al., 1991). To make the construct that drives
ectopic Mfng expression, a plasmid that carries the full coding region of Mfng
(Cohen et al., 1997; gifts from S.E. Egan) was digested with HindIII and NotI
and filled in. The cDNA fragment was purified and ligated into the EcoRV site
pCIG vector (Niwa et al., 1991). The dominant-negative mouse Myt1-producingplasmid is reported earlier (Gu et al., 2004). The constitutively active notch
(NICD)-producing construct is a gift from Dr. Daisuke Kitamura, University of
Tokyo.
Chick embryo electroporation
Chick embryo electroporation follows the reported protocol (Grapin-Botton
et al., 2001). Briefly, fertilized leghorn eggs were incubated at 38°C with
periodic rotation. When embryos reach around 15–20 somite-stage [Hamburg-
Hamilton (HH) stage 13–14, equivalent to E9.5 in mouse; Hamburger, 1992],
eggs were windowed and DNA (0.2–0.5 μg/μL sample DNA plus pCIG vector
to make final DNA concentration to 2 μg/μL in 1xPBS, 1 mMMgCl2, 3 mg/ml
carboxymethylcellulose, 0.5% Indian ink) was injected in the blastocoel and
electroporated. After electroporation, eggs were incubated at 38°C for 48 or 72
more hours for analysis. Under this electroporation regime, the ectopic Mfng
mRNA level is similar to that of the endogenous cRfng or cLfng in the nervous
system (as judged by the time required to visualize the message using in situ
hybridization).
In situ hybridization
Mouse or chicken tissues were collected at desired stages, fixed in 4%
paraformaldehyde, and prepared as frozen or paraffin sections. In situ
hybridization followed described procedure (Gu et al., 2004). Final signal
visualization was achieved by alkaline phosphotase staining as a blue color. In
order to generate the cRNA probes, either PCR amplified cDNA fragments or
cloned cDNA plasmids were utilized. cMfng, cLfng, cMyt1, cMyt3, and cNgn3
were directly amplified by the following primer pairs: cMfng-f (forward):
5′-ctctgagctgcagtcaaaaaacc-3′; cMfng-r (reverse): 5′-atcgtaatacgactcactatagcatg-
gcagctcct-cacagcagaga-3′; c-Lfng-f: 5′-ctcccaaatctcagcatcgaggct-3′; cLfng-r:
5′-atcgtaatacgactcac-tataggctgctttattggtgacggtgg-3′; cMyt1-f: 5′-caaggagctgga-
gaagtactccaag-3′; cMyt1-r: 5′-atcgtaatacgactcactatagtgttctctgggttctggtagcac-3′;
cMyt3-f; 5′-ggactcatcacctgtccgactcca-3′; cMyt3-r: 5′-atcgtaatacgactcactatag-
aatatgcccgttc-cagattgct-3′; cNgn3-f: 5′-gcttaacggcagtcgtgtgccggcc-3; cNgn3-r:
5′-atcgtaatacgactcactata-gggtctgaccgcgacacactttattctcc-3′. The presence of the
T7 promoter sequence in the reverse primer allows for direct anti-sense probes
production. To generate cRNA probes for cNotch1, cNotch2, cDelta1, cSerrate
(gifts from Dr. Kitamura), cNkx2.2 (gift from T. Jessell), cNkx6.1 (a gift from T.
Jessell), cHlxB9 (Tanabe et al., 1998; a gift from T. Jessell), cNeuroD (a gift from
T, Jessell), cHes1 (Vasiliauskas et al., 2003; a gift from D. Vasiliauskas),
plasmids were utilized.
Immunohistochemistry
Eelectroporated embryos were dissected and fixed in 4% paraformaldehyde
for 4 h on ice. Tissues could either be prepared as frozen sections to preserve the
GFP fluorescence, or as paraffin sections to preserve morphology. Primary
antibodies used: guinea pig-anti-insulin (Dako, Carpinteria, CA), rabbit-anti-
glucagon (In vitrogen, Carlsbad, CA), Rabbit anti-SS (In vitrogen, Carlsbad,
CA) and rabbit anti-PP (In Vitrogen. Carlsbad, CA), rabbit anti-amylase (Sigma
Aldrich, St. Louis, MO), mouse anti-cIsl-1, and mouse anti-cPax6 (Hybridoma,
University of Iowa, IA), and mouse anti-Ngn3 (a gift from M. Magnuson).
Secondary antibodies used: peroxidase-conjugated-donkey anti-guinea pig or
rabbit IgG, Cy3-conjugated donkey anti-rabbit IgG, Cy3-conjugated donkey
anti-guinea pig IgG (Jackson Immunoresearch, West Grove, PA). In order to
show the co-expression of mRNA and protein antigens, in situ hybridization was
performed first. After color development, slides were re-fixed in 4%
paraformaldehyde overnight at 4°C and proceed for routine immunohistochem-
istry. For Ngn3 detection, antigen retrieval was performed.
Statistical analysis
In order to quantify the efficiency of endocrine induction by Mfng, 0.5 μg/
μL Mfng was used for hormone induction. For Fig. 2, pancreata that have GFP
expression were prepared as 20 μm frozen sections. Alternative sections were
stained for endocrine or exocrine markers, respectively. Confocal images were
taken as Z-sections at 3-μm-intervals. The number of cells that have GFP,
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5, whole mount immunofluorescence was used to visualize the glucagon
expressing cells. Confocal images were taken as Z-sections at 3-μm-intervals.
The numbers of cells that express GFP and/or glucagon were counted in all
sections. The ratio of hormone+ cells/GFP+ cells was used as an indicator of
endocrine inducing efficiency.
Results
Mfng is expressed in a subset of pancreatic cells throughout
embryogenesis
In order to reveal possible modifiers that initiate endocrine
differentiation, we have used a microarray-based method to
identify transcripts that are expressed in the Ngn3-expressing
(Ngn3+) endocrine progenitors. This analysis has identified
Mfng as a transcript that is present in Ngn3+ cells, but not in
Ngn3− precursors of the pancreas at a significant level (Gu et al.,
2004).
We verified Mfng expression in the developing mouse
pancreas by in situ hybridization. Consistent with published
data (Johnston et al., 1997), abundant Mfng transcripts were
detected in the developing nervous system (Fig. 1A). Mfng
transcripts were also detected in a subset of pancreatic epithelial
cells at E9.5, E10.5, E14 and E16.5 (Figs. 1B–E). These cells
locate in cell clusters from which endocrine progenitors
differentiate, as evidenced by the expression of Ngn3 in similar
domains (Fig. 1F). Mfng expression was not detected in the
stomach or duodenal epithelium at E10.5 and E14, the two
stages examined (Fig. 1C and data not shown).
We further determined the identity of these Mfng-expressing
cells. E14.5 or E15.5 pancreatic sections were stained to
visualize Mfng mRNA by in situ hybridization. Antibodies
against insulin, glucagon, Ngn3, or amylase were then utilized
to examine whether any of the Mfng+ cells express these
markers. As shown in Figs. 1G–I, Mfng+ cells do not express
glucagon, insulin (Fig. 1G), or amylase (Fig. 1H), whereas most
(28/36) of the Mfng+ cells express Ngn3 (Fig. 1I), although
most (123/162) of the Ngn3+ cells do not have detectable Mfng
mRNA. These expression data are consistent with a hypothesis
that the Mfng+ precursors might give rise to the Ngn3+
endocrine islet cells. It is likely that Mfng expression is turned
on to initiate Ngn3 expression, then turned off. We could
therefore observe a partial overlap of Ngn3 and Mfng
expression. Alternatively, the Mfng+ cells could behave as
stem cells to constantly produce Ngn3+ precursors. We are
currently unable to differentiate these possibilities.
We also examined the expression of Lfng and Rfng in mouse
embryos at E10.5 and E14, we found no detectable expression in
the pancreatic epithelium (data not shown). These data are
consistent with our microarray-based analyses and they suggest
thatMfng is the major Fng family member for islet development.
Mfng induces endocrine differentiation in chicken embryonic
endodermal cells
Mfng modifies Notch signaling, either enhancing or
inhibiting Notch activity in a cell type-dependent manner(Hicks et al., 2000; Shimizu et al., 2001; Yang et al., 2005). It
is likely that its expression could initiate endocrine differen-
tiation. To test this hypothesis, chicken epithelial gut cells
were used for this assay. These cells are responsive to
endocrine-inducing signals (Grapin-Botton et al., 2001). We
used CMV-βactin promoter in the pCIG vector to drive
ectopic Mfng expression. The CMV-βactin promoter drives
ectopic gene expression at physiological level when plasmid
concentration is properly controlled (Dasen et al., 2003; Stern,
2005; Tanabe et al., 1998). A bi-cistronic expression construct
that carries mouse Mfng and nuclear GFP cDNA
(Mfng + GFP) was electroporated into embryonic chicken
gut cells between the 15 to 20-somite stages (stage HH13,
equivalent to E9.5 in mouse embryos; Hamburger, 1992). The
expression of endocrine hormones or exocrine enzymes in the
pancreas or other gut region was examined 2 or 3 days after
electroporation.
Pancreata that ectopically expressed GFP or (Mfng + GFP)
were fixed and prepared as frozen sections. The expression of
glucagon and insulin in the GFP+ cells was determined by
confocal immunofluorescence. We found that the presence
of Mfng significantly increased the frequency of pancre-
atic precursor cells adopting islet fates (Figs. 2A–C).
Conversely, the presence of Mfng in pancreatic progenitors
effectively prevented these cells from adopting acinar fates
(Figs. 2D–F). These results suggest that Mfng expression
induces precocious endocrine differentiation in pancreatic
progenitors.
The production of ectopic endocrine hormones outside the
pancreatic region was analyzed 2 days after Mfng electro-
poration, when electroporated cells started to delaminate
from the epithelium, or 3 days after electroporation, when
most of the electroporated cells were found outside of the
gut epithelium. Ectopic Mfng expression induced the
production of all four pancreatic hormones along the gut
tube, including the foregut (anterior to the stomach-duodenal
junction; Grapin-Botton, 2005), midgut (stomach-duodenal
junction to the umbilicus), and hindgut regions (posterior to
the umbilicus; Fig. 3 and data not shown). Notably, the
glucagon+ cells account for a large majority of the ectopic
endocrine cells (92% of the ectopic islet cells from 12
independent electroporations), whereas the insulin, SS, or
PP-producing cells accounted for a smaller portion of the
induced endocrine cells (1%, 5%, and 2%, respectively).
Induction of these three later hormones was confirmed by
antibodies against insulin c-peptide or by RT-PCR (Supple-
mentary Fig. 1). We also varied the level of ectopic Mfng
expression by electroporating lower concentrations of Mfng-
producing plasmids (data not shown). The reduction in Mfng
expression level, as determined by in situ hybridization, did
not compromise ectopic endocrine induction.
One other observation for Mfng-induced endocrine
differentiation is that the ectopic hormone-positive cells
always express lower levels of GFP (Supplementary Fig. 2).
Most of the cells that express high level of GFP do not
express endocrine hormones. One possible explanation for
this observation is that differentiated endocrine cells could
Fig. 1.Mfng expression in developing mouse pancreas. (A) E9.5, Mfng expression in the neural tube (red arrowhead) and a subset of pancreatic epithelial cells
(black arrowhead). Duodenal epithelium is circled with black broken lines. (B) Mfng expression in dissected pancreatic epithelium (red broken lines),
recognized by the organization pattern and morphology of the nuclei. (C) Mfng expression in the mesenchyme (arrowhead) but not in the duodenal epithelium
(black broken lines). (D, E) Mfng expression in cells (black arrowheads) in a duct-like epithelial structure (red broken lines), but not in exocrine tissues at E14
and E16.5, respectively (green arrowhead). (F) Ngn3 expression in E16.5 pancreas, as a control for panel E. (G) Mfng+ cells (black arrowhead) do not express
endocrine hormones (red arrow, stained brown with a mixture of glucagon and insulin antibodies). (H) Mfng+ cells (black arrowhead) do not express amylase
(brown). Note the separation of blue Mfng mRNA staining and brown amylase staining. (I) A portion of Mfng+ cells (blue) express Ngn3 protein (brown
staining). Note the presence of Mfng−Ngn3+ (green arrow), Mfng+Ngn3+ (red arrows), and Mfng+Ngn3− cells (black arrowhead). The inset highlights one
of the Mfng+Ngn3+ cells, with nuclear brown Ngn3 immunostaining and cytoplasmic Mfng mRNA blue stain. Pan: pancreas. Duo: duodenum. Scale
bars = 20 μm.
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A second possibility is that only cells that express proper
amount of Mfng activity could differentiate. A third
possibility is that differentiated endocrine cells could divide
faster to dilute the electroporated GFP constructs. We are
currently unable to differentiate these possibilities.
Both Lfng and Rfng can induce endocrine differentiation
when electroporated as Mfng (data not shown), suggesting that
these three molecules have overlapping activities.
Mfng activity requires Notch repression
Since Fng modifies Notch, Fng may induce endocrine
differentiation by inhibiting Notch signaling. We examined the
expression pattern of several Notch signaling components in
developing chicken gut cells. Similar to mouse or rat
(Apelqvist et al., 1999; Hald et al., 2003; Lammert et al.,
2000), the early chicken gut cells maintain broadly active
Notch signaling. cHes1, a target gene of Notch signaling(Jouve et al., 2000), is actively expressed in most, if not all of
the gut cells (Figs. 4A, B). cNotch2, cJagged2/Serrate2, and
cDelta1 are also expressed in the embryonic gut epithelial cells
(data not shown). cLfng, cNotch1, and cRfng are only
expressed in the mesenchymal cells of the gut (data not
shown). We also detected cMfng message in chicken pancreatic
epithelium using RT-PCR (Supplementary Fig. 3). Because its
expression level is too low to be detected by in situ
hybridization, we do not know which pancreatic cell type
expresses cMfng. It is possible that a low level of cMfng
protein could provide enough enzymatic activity to modify
Notch signaling in the developing pancreas.
If inactivation of Notch signaling is required for Mfng
activity, a constitutively active Notch molecule (NICD) should
inhibit ectopic endocrine differentiation and ectopic Mfng
might induce ectopic expression of cNgn3, an established Notch
target. Indeed, glucagon induction by Mfng was effectively
blocked by NICD (Figs. 4C, D). Additionally, ectopic Mfng
expression induced a high level of cNgn3 expression in the
Fig. 2. Ectopic Mfng expression in embryonic chicken pancreas promotes endocrine differentiation but inhibits exocrine differentiation 2 days after electroporation.
(A, B) Insulin and glucagon expression (red) in pancreatic cells electroporated with GFP or (Mfng + GFP), respectively. Note that only a few cells that express
GFP alone express endocrine hormones (A, blue arrow, recognized by the presence of GFP in the nuclei and hormones in the surrounding cytoplasm), whereas
many cells that express Mfng become hormone-positive (B, blue arrows). Not all Mfng-expressing cells are hormone-positive at this stage (yellow arrows). (C) The
percentage of electroporated cells that differentiated towards endocrine fate (Endo/GFP+). (D, E) Amylase expression in pancreata electroporated with GFP or
(Mfng + GFP). GFP+amylase+ cells (blue arrows) are recognized by green nuclei surrounded by cytoplasmic amylase, stained red. Some GFP+amylase− cells are
marked with yellow arrows. (F) The percentage of electroporated cells that expressed amylase (Exo/GFP+). Scale bar = 20 μm.
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already left the epithelium, although rare cNgn3+ cells can also
be found within the epithelium (Figs. 4E, F). These data suggestFig. 3.Mfng ectopic expression in chicken embryonic gut cells induces islet differenti
the brown color from horseradish peroxidase detection. Glucagon (glc, 1), insulin (i
endogenous pancreas (A), hindgut cells receiving ectopic Mfng (B), and hindgut ce
ectopic glucagon expression could be observed in nearly all sections, whereas insuli
Scale bar = 50 μm.that Notch inactivation is required for Mfng-induced endocrine
differentiation and Mfng induces islet differentiation through
the Notch-Ngn cascade.ation. Three days after electroporation, hormone-producing cells were marked by
ns, 2), somatostatin (ss, 3), and pancreatic polypeptide (pp, 4) expression in the
lls receiving GFP expression, respectively (C). For all electroporated samples,
n, SS, and PP-producing cells could be found only in a fraction of the sections.
Fig. 5. Mfng induces ectopic expression of cMyt1 and cMyt3. (A, B) expression
of cMyt1 and cMyt3 in a non-electroporated pancreas 6 days after incubation.
Brown indicates glucagon-producing cells. Blue indicates the presence of cMyt1
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Myt1 is a zinc finger transcription factor that induces
endocrine differentiation in chicken embryonic gut cells (Gu et
al., 2004). To determine whether Myt1 constitutes part of an
Mfng-Notch-Ngn endocrine differentiation program, we exam-
ined cMyt1 expression following Mfng ectopic expression.
Mammals have three Myt1 paralogs: Myt1, Myt1L (Kim
et al., 1997), and Myt3 (or st18; Jandrig et al., 2004). Using
a combination of bioinformatics and RT-PCR, we have
identified three chicken Myt1 orthologs, cMyt1, cMyt1l, and
cMyt3, and the predicted proteins share 67%, 79%, and 72%
identity with mouse Myt1, Myt1L, and Myt3, respectively.
cMyt1 expression in the developing chicken pancreas is
detectable by RT-PCR, but not by in situ hybridization (Fig.
5A and data not shown). By contrast, in situ hybridization
detected a high level of cMyt3 expression in the developing
pancreatic epithelium (Fig. 5B). cMyt1L expression was not
detected by RT-PCR or in situ (data not shown) and was not
investigated further.Fig. 4. Mfng induces endocrine differentiation through Notch-Ngn pathway.
(A, B) cHes-1 expression in chicken gut cells (black broken lines), detected by
in situ hybridization. In panel A, the gut tube is not closed yet (HH stage 13).
In panel B, the gut tube is closed (HH stage 18, equivalent to E10.5 in mouse).
The visceral endoderm does not express cHes1 (green broken lines). (C, D)
Ectopic glucagon expression in the absence or presence of NICD, respectively.
The gut epithelium is indicated by white broken lines, and hormone-expressing
cells by green broken lines. (E) cNgn3 in control gut without Mfng ectopic
expression. Green arrow, endogenous pancreas. Black arrow, stomach. Black
broken lines: the gut epithelium. (F) Three examples of ectopic Mfng-induced
cNgn3 expression. Brown staining indicates the position of ectopic glucagon+
cells. Blue color is produced by cNgn3 in situ (red arrow). Black broken lines:
the gut epithelium. Scale bars = 20 μm.
or cMyt3 mRNA. (C, D) Ectopic cMyt1 or cMyt3 expression induced by Mfng.
Mfng-expressing cell clusters is marked by the ectopic glucagon expression
(brown staining). Scale bars = 20 μm.As shown in Figs. 5C and D, we found that both cMyt1 and
cMyt3 were induced by ectopic Mfng expression, with their
expression patterns closely matched to the pattern of ectopic
glucagon expression, suggesting that Myt zinc finger proteins
might be mediators of Mfng activity.
Deleting the transcription activation domain of Myt1 creates
a dominant negative molecule that effectively inhibits the
function of the wild typeMyt1 in mouse, chicken, Xenopus, and
cultured cells (Bellefroid et al., 1996; Gu et al., 2004; Romm et
al., 2005). Because Myt1, cMyt1, and cMyt3 have nearly
identical zinc fingers, we anticipated that dnMyt1 would inhibit
the function of both cMyt1 and cMyt3. We therefore utilized
this dominant negative molecule to determine whether cMyt1/
cMyt3 activation is required for the endocrine-inducing ability
of Mfng. Co-electroporation of Mfng and dnMyt1 expression
plasmids resulted in a significant decrease in ectopic glucagon
induction (Fig. 6). Conversely, inclusion of Myt1 partially
relieved the inhibitory effect of dnMyt1 (data not shown).
Combined with our result that Myt1 is sufficient to induce
endocrine production (Gu et al., 2004), these new findings
suggest that Mfng play a role in islet differentiation, at least
partly, through the Myt proteins-either cMyt1 or cMyt3, or both.
Mfng expression partially activates the endocrine
differentiation program
Several transcription factors are required for endocrine
differentiation, and their expression mark discrete stages of islet
formation. For example, Pdx1 expression marks the generation
of pancreatic progenitors (Ohlsson et al., 1993; Gu et al., 2002)
or β cells (Offield et al., 1996). HlxB9, Isl1, Pax6, NeuroD,
Nkx2.2, and Nkx6.1 lie downstream of Ngn3 and their
expression marked committed endocrine cells (Ahlgren et al.,
Fig. 6. dnMyt1 inhibits Mfng-induced endocrine differentiation. (A, B) Ectopic glucagon+ cells (red) induced by Mfng (green GFP fluorescence) in the absence (A) or
presence (B) of dnMyt1. (C) When GFP alone is ectopically expressed, no ectopic glucagon expression can be detected. Note that most of the electroporated cells stay
within the epithelium. Inset in panel C, glucagon staining in the endogenous pancreas. (D) Percent of GFP+ cells that are also glucagon+. Scale bar = 20 μm.
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2000; St-Onge et al., 1997; Sussel et al., 1998). If Mfng initiates
the normal endocrine program, we expect that these transcrip-
tion factors could also be induced. Indeed, Mfng ectopic
expression induces the expression of cPax6, cNkx2.2, cNkx6.1,
cHlxB9, cIslI, and cNeuroD (Fig. 7 and Supplementary Fig. 4).
However, ectopic Mfng expression does not activate cPdx1
expression (data not shown). These results suggest that Mfng
partially activates the endocrine program, and the generation of
the ectopic endocrine cells could by-pass the function of Pdx1.Fig. 7. Mfng induces the expression of several transcription factors in the hindgut ce
cNkx6.1, and cNeuroD 2 days after electroporation. Panels A, B, C, and inset in pan
expression. At this stage, some electroporated cells have already budded into surroun
detects ectopic cIsl1 and cPax6 expression. Note the transcription factor-expressing ce
Scale bar = 20 μm.In addition, the ability of Mfng to activate the expression of
these endocrine transcription factors suggests that, like Ngn3,
Mfng acts at early steps of endocrine differentiation.
Discussion
In the developing pancreas, a major unanswered question
concerns the mechanisms that repress Notch signaling to initiate
endocrine differentiation. We report that Mfng overexpression
induces the production of all four major pancreatic islet celllls. (A–D) In situ hybridization detects ectopic expression of cHlxB9, cNkx2.2,
el C used paraffin sections from a same hindgut. Inset in C shows ectopic Mfng
ding mesenchyme (green arrowhead in panel C). (E, F) Immunohistochemistry
ll clusters (arrowhead) located outside of the gut epithelium (black broken lines).
347Y. Xu et al. / Developmental Biology 297 (2006) 340–349types in non-pancreatic endoderm. Ectopic Mfng also induces
the expression of cNgn3, cMyt1, and cMyt3, molecules that are
sufficient to activate islet differentiation (Apelqvist et al., 1999;
Grapin-Botton et al., 2001; Gu et al., 2004; Schwitzgebel et al.,
2000). To the best of our knowledge, this is the only gene
product that has so far been shown to have this property.
Our findings suggest that Mfng regulates pancreatic
endocrine development through a Notch-Ngn3-Myt1 cascade
(Fig. 8). Several observations support this hypothesis. First, it is
well established that Fng molecules act by glycosylating the
Notch receptors (Panin et al., 1997). Second, Mfng is unable to
induce endocrine differentiation in the presence of constitu-
tively active Notch signaling. Third, during islet differentiation,
Mfng transcripts are mainly detected within Ngn3-expressing
cells. Fourth, Mfng activates the expression of cNgn3 and
cMyt1/cMyt3, which are known to be negatively regulated by
Notch signaling (Bellefroid et al., 1996). Finally, dnMyt1
inhibits Ngn3-induced endocrine differentiation (Gu et al.,
2004).
One caveat for our analysis is that we could not detect Hes1
down-regulation in the epithelial cells that ectopically express
Mfng (data not shown). One possible explanation for this
finding is that Mfng does not induce endocrine differentiation
through Notch. As discussed above, this is an unlikely scenario.
Alternatively, the cells that have turned off Notch-Hes1 activity
could quickly exit the epithelium, thus made it difficult to detect
the cells that have turned off Hes1 expression. We favor this
second possibility. As shown by our Ngn3 expression analyses,
most of the Ngn3+ cells are located outside of the epithelium.
Neither do our studies address whether Mfng is required for
endocrine islet differentiation. Due to possible functional
compensation or up-regulation of Lfng and Rfng in prospective
mutants, it is likely that a triple Fngmutant mouse is required to
address this question. In addition, even though cNotch2, cSer1,
and cDelta1 are expressed in the embryonic gut cells, we do not
have the expression information of all chicken notch compo-
nents. Therefore, which Notch-ligand interaction is mediatingFig. 8. A proposed model for endocrine development initiation.Mfng expression
inhibits Notch signaling suppression. This leads to the expression of Ngn3, and
then Myt1, which activates the endocrine differentiation program.the endocrine-inducing activity of Mfng remains unknown.
Finally, we do not know whether Mfng expression also plays a
role in exocrine differentiation. As reported by several previous
studies (Esni et al., 2004; Hald et al., 2003; Murtaugh et al.,
2003), Notch inactivation is also required for exocrine
differentiation. Similar results were observed in chicken
exocrine differentiation—ectopic NICD expression also inhi-
bits amylase expression in chicken embryonic pancreas (Xu and
Gu, unpublished data). Although ectopic Mfng expression in
early embryonic stage failed to induce exocrine tissue
production (data not shown), we do not know whether Mfng
or its paralogs can do so if expressed at later stages.
Neither Ngn3 nor Myt1 could induce insulin production
when ectopically expressed in embryonic gut cells (Grapin-
Botton et al., 2001; Gu et al., 2004). It is therefore likely that
Ngn3 and Myt1 constitute a subset of the endocrine-induction
cascade initiated by Notch repression, and that other gene
products cooperate with Ngn3 and Myt1 to determine which
endocrine fates to adopt. Alternatively, Mfng needs some time
to active cNgn3 or cMyt expression when electroporated. This
extra time could allow the gut cells to gain the competence to
produce insulin. In this case, we predict that electroporating
Ngn3 or Myt1 at a later stage could also induce insulin
production. Evidence for this possibility exists: it has been
shown that the gut cells' ability to respond to mesodermal
inductive signals changes over time (Kumar et al., 2003).
Unfortunately, we can target endodermal cells only around a
short time window, around HH13 (before gut closing); this later
possibility cannot be directly addressed.
All electroporated cells do not differentiate along the
endocrine pathway. At least two possible mechanisms could
explain this finding. First, a specific level of Mfng activity is
required for gut cells to differentiate down the endocrine pathway
and electroporation introduces different Mfng levels in different
cells. Because we observed similar endocrine differentiation
patternwhen variousMfng levels were introduced, this possibility
is unlikely to occur. Second, only a subset of the gut progenitor
cells is competent to adopt endocrine fates. Due to the lack of
specific gut cell markers and the technical difficulty to target
specific gut progenitors, we could not test this hypothesis directly.
Neither could we determine whether all four types of hormone-
producing cells arise from a set of common progenitors.
Similar to Ngn3, Mfng does not induce ectopic cPdx1
expression, demonstrating that Mfng is not sufficient to re-
specify hindgut cells to full pancreatic fates. Yet the ectopic
induction of several other transcription factors required for islet
differentiation suggests that Mfng is sufficient to convert gut
cells to endocrine islet cells. During mouse pancreatic
development, two waves of endocrine differentiation occur.
The wave I endocrine cells appear between E9.5 and E12.5 and
they contain glucagon+ and insulin+ cells, but not SS+ or PP+
cells. The generation of these endocrine cells is Pdx1-
independent (Offield et al., 1996). The wave II endocrine
cells, including all four major islet cell types, appear after E12.5
(Jensen et al., 2000a). The production of these cells depends on
Pdx1 function (Jonsson et al., 1994; Offield et al., 1996).
Because Mfng-induced islets are overwhelmingly composed of
348 Y. Xu et al. / Developmental Biology 297 (2006) 340–349glucagon+ cells and this induction occurs in the apparent
absence of Pdx1, it is likely that at the stage when Mfng is
electroporated, the endodermal cells could mostly undergo wave
I endocrine differentiation, but only minimally wave II islet
formation (to produce SS and PP-positive cells). Nevertheless,
the result that Mfng induces endocrine differentiation in
embryonic endoderm, coupled with the finding that Mfng is
only expressed in endocrine progenitors, lends invaluable
information on the possible roles of the glycosyl-transferase in
endocrine differentiation.
Acknowledgments
We are grateful to Chris Wright for comments on the
manuscript. We thank Anne Grapin-Botton for help in chicken
embryo electroporation, and thank Tsutomu Kume for technical
help with in situ hybridization. This research was supported by a
DRTC pilot grant (DK20593 P and F) from Vanderbilt Medical
Center, a grant from the NIH (1RO1 DK065949-01A1), and a
JDRF Career Development Award (# 2003-651) to Guoqiang
Gu.
Appendix A. Supplementary data
Supplementary data associated with this article can be found,
in the online version, at doi:10.1016/j.ydbio.2006.04.456.
References
Ahlgren, U., Pfaff, S.L., Jessell, T.M., Edlund, T., Edlund, H., 1997.
Independent requirement for ISL1 in formation of pancreatic mesenchyme
and islet cells. Nature 385, 257–260.
Apelqvist, A., Li, H., Sommer, L., Beatus, P., Anderson, D.J., Honjo, T., Hrabe
de Angelis, M., Lendahl, U., Edlund, H., 1999. Notch signalling controls
pancreatic cell differentiation. Nature 400, 877–881.
Bellefroid, E.J., Bourguignon, C., Hollemann, T., Ma, Q., Anderson, D.J.,
Kintner, C., Pieler, T., 1996. X-MyT1, a Xenopus C2HC-type zinc finger
protein with a regulatory function in neuronal differentiation. Cell 87,
1191–1202.
Blair, S.S., 2000. Notch signaling: fringe really is a glycosyltransferase. Curr.
Biol. 10, R608–R612.
Cohen, B., Bashirullah, A., Dagnino, L., Campbell, C., Fisher, W.W., Leow,
C.C., Whiting, E., Ryan, D., Zinyk, D., Boulianne, G., et al., 1997.
Fringe boundaries coincide with Notch-dependent patterning centres in
mammals and alter Notch-dependent development in Drosophila. Nat.
Genet. 16, 283–288.
Collombat, P., Mansouri, A., Hecksher-Sorensen, J., Serup, P., Krull, J.,
Gradwohl, G., Gruss, P., 2003. Opposing actions of Arx and Pax4 in
endocrine pancreas development. Genes Dev. 17, 2591–2603.
Collombat, P., Hecksher-Sorensen, J., Broccoli, V., Krull, J., Ponte, I., Mundiger,
T., Smith, J., Gruss, P., Serup, P., Mansouri, A., 2005. The simultaneous loss
of Arx and Pax4 genes promotes a somatostatin-producing cell fate
specification at the expense of the (alpha)- and (beta)-cell lineages in the
mouse endocrine pancreas. Development 132, 2969–2980.
Dasen, J.S., Liu, J.P., Jessell, T.M., 2003. Motor neuron columnar fate imposed
by sequential phases of Hox-c activity. Nature 425, 926–933.
Edlund, H., 1999. Pancreas: how to get there from the gut? Curr. Opin. Cell Biol.
11, 663–668.
Edlund, H., 2001. Developmental biology of the pancreas. Diabetes 50
(Suppl. 1), S5–S9.
Esni, F., Ghosh, B., Biankin, A.V., Lin, J.W., Albert, M.A., Yu, X., MacDonald,
R.J., Civin, C.I., Real, F.X., Pack, M.A., Ball, D.W., Leach, S.D., 2004.Notch inhibits Ptf1 function and acinar cell differentiation in developing
mouse and zebrafish pancreas. Development 131, 4213–4224.
Evrard, Y.A., Lun, Y., Aulehla, A., Gan, L., Johnson, R.L., 1998. lunatic fringe
is an essential mediator of somite segmentation and patterning. Nature 394,
377–381.
Gradwohl, G., Dierich, A., LeMeur, M., Guillemot, F., 2000. neurogenin3 is
required for the development of the four endocrine cell lineages of the
pancreas. Proc. Natl. Acad. Sci. U. S. A. 97, 1607–1611.
Grapin-Botton, A., 2005. Antero-posterior patterning of the vertebrate digestive
tract: 40 years after Nicole Le Douarin's PhD thesis. Int. J. Dev. Biol. 49,
335–347.
Grapin-Botton, A., Majithia, A.R., Melton, D.A., 2001. Key events of pancreas
formation are triggered in gut endoderm by ectopic expression of pancreatic
regulatory genes. Genes Dev. 15, 444–454.
Gu, G., Dubauskaite, J., Melton, D.A., 2002. Direct evidence for the pancreatic
lineage: NGN3+ cells are islet progenitors and are distinct from duct
progenitors. Development 129, 2447–2457.
Gu, G., Wells, J.M., Dombkowski, D., Preffer, F., Aronow, B., Melton, D.A.,
2004. Global expression analysis of gene regulatory pathways during
endocrine pancreatic development. Development 131, 165–179.
Hahn, K.L., Johnson, J., Beres, B.J., Howard, S., Wilson-Rawls, J., 2005.
Lunatic fringe null female mice are infertile due to defects in meiotic
maturation. Development 132, 817–828.
Haines, N., Irvine, K.D., 2003. Glycosylation regulates Notch signalling. Nat.
Rev., Mol. Cell Biol. 4, 786–797.
Hald, J., Hjorth, J.P., German, M.S., Madsen, O.D., Serup, P., Jensen, J., 2003.
Activated Notch1 prevents differentiation of pancreatic acinar cells and
attenuate endocrine development. Dev. Biol. 260, 426–437.
Hamburger, V.a.H., HL., 1992. A series of normal stages in the developmental of
the chick embryo.
Harmon, E.B., Apelqvist, A.A., Smart, N.G., Gu, X., Osborne, D.H., Kim, S.K.,
2004. GDF11 modulates NGN3+ islet progenitor cell number and promotes
beta-cell differentiation in pancreas development. Development 131,
6163–6174.
Harrison, K.A., Thaler, J., Pfaff, S.L., Gu, H., Kehrl, J.H., 1999. Pancreas dorsal
lobe agenesis and abnormal islets of Langerhans in Hlxb9-deficient mice.
Nat. Genet. 23, 71–75.
Hart, A., Papadopoulou, S., Edlund, H., 2003. Fgf10 maintains notch activation,
stimulates proliferation, and blocks differentiation of pancreatic epithelial
cells. Dev. Dyn. 228, 185–193.
Hicks, C., Johnston, S.H., diSibio, G., Collazo, A., Vogt, T.F., Weinmaster, G.,
2000. Fringe differentially modulates Jagged1 and Delta1 signalling through
Notch1 and Notch2. Nat. Cell Biol. 2, 515–520.
Hill, D.J., 2005. Development of the endocrine pancreas. Rev. Endocr. Metab.
Disord. 6, 229–238.
Hukriede, N.A., Gu, Y., Fleming, R.J., 1997. A dominant-negative form of
Serrate acts as a general antagonist of Notch activation. Development 124,
3427–3437.
Irvine, K.D., Wieschaus, E., 1994. Fringe, a boundary-specific signaling
molecule, mediates interactions between dorsal and ventral cells during
Drosophila wing development. Cell 79, 595–606.
Jandrig, B., Seitz, S., Hinzmann, B., Arnold, W., Micheel, B., Koelble, K.,
Siebert, R., Schwartz, A., Ruecker, K., Schlag, P.M., et al., 2004. ST18 is a
breast cancer tumor suppressor gene at human chromosome 8q11.2.
Oncogene 23, 9295–9302.
Jensen, J., 2004. Gene regulatory factors in pancreatic development. Dev. Dyn.
229, 176–200.
Jensen, J., Heller, R.S., Funder-Nielsen, T., Pedersen, E.E., Lindsell, C.,
Weinmaster, G., Madsen, O.D., Serup, P., 2000a. Independent development
of pancreatic alpha- and beta-cells from neurogenin3-expressing precursors:
a role for the notch pathway in repression of premature differentiation.
Diabetes 49, 163–176.
Jensen, J., Pedersen, E.E., Galante, P., Hald, J., Heller, R.S., Ishibashi, M.,
Kageyama, R., Guillemot, F., Serup, P., Madsen, O.D., 2000b. Control of
endodermal endocrine development by Hes-1. Nat. Genet. 24, 36–44.
Johnston, S.H., Rauskolb, C., Wilson, R., Prabhakaran, B., Irvine, K.D., Vogt,
T.F., 1997. A family of mammalian Fringe genes implicated in boundary
determination and the Notch pathway. Development 124, 2245–2254.
349Y. Xu et al. / Developmental Biology 297 (2006) 340–349Jonsson, J., Carlsson, L., Edlund, T., Edlund, H., 1994. Insulin-promoter-factor
1 is required for pancreas development in mice. Nature 371, 606–609.
Jouve, C., Palmeirim, I., Henrique, D., Beckers, J., Gossler, A., Ish-Horowicz,
D., Pourquie, O., 2000. Notch signalling is required for cyclic expression of
the hairy-like gene HES1 in the presomitic mesoderm. Development 127,
1421–1429.
Kim, S.K., Hebrok, M., 2001. Intercellular signals regulating pancreas
development and function. Genes Dev. 15, 111–127.
Kim, S.K., MacDonald, R.J., 2002. Signaling and transcriptional control of
pancreatic organogenesis. Curr. Opin. Genet. Dev. 12, 540–547.
Kim, J.G., Armstrong, R.C., v Agoston, D., Robinsky, A., Wiese, C., Nagle, J.,
Hudson, L.D., 1997. Myelin transcription factor 1 (Myt1) of the
oligodendrocyte lineage, along with a closely related CCHC zinc finger, is
expressed in developing neurons in the mammalian central nervous system.
J. Neurosci. Res. 50, 272–290.
Kumar, M., Jordan, N., Melton, D., Grapin-Botton, A., 2003. Signals from
lateral plate mesoderm instruct endoderm toward a pancreatic fate. Dev.
Biol. 259, 109–122.
Kume, S., 2005. The molecular basis and prospects in pancreatic development.
Dev. Growth Differ. 47, 367–374.
Lammert, E., Brown, J., Melton, D.A., 2000. Notch gene expression during
pancreatic organogenesis. Mech. Dev. 94, 199–203.
Melloul, D., 2004. Transcription factors in islet development and phy-
siology: role of PDX-1 in beta-cell function. Ann. N. Y. Acad. Sci.
1014, 28–37.
Murtaugh, L.C., Stanger, B.Z., Kwan, K.M., Melton, D.A., 2003. Notch
signaling controls multiple steps of pancreatic differentiation. Proc. Natl.
Acad. Sci. U. S. A. 100, 14920–14925.
Naya, F.J., Huang, H.P., Qiu, Y., Mutoh, H., DeMayo, F.J., Leiter, A.B., Tsai,
M.J., 1997. Diabetes, defective pancreatic morphogenesis, and abnormal
enteroendocrine differentiation in BETA2/neuroD-deficient mice. Genes
Dev. 11, 2323–2334.
Niwa, H., Yamamura, K., Miyazaki, J., 1991. Efficient selection for high-
expression transfectants with a novel eukaryotic vector. Gene 108,
193–199.
Norgaard, G.A., Jensen, J.N., Jensen, J., 2003. FGF10 signaling maintains the
pancreatic progenitor cell state revealing a novel role of Notch in organ
development. Dev. Biol. 264, 323–338.
Ohlsson, H., Karlsson, K., Edlund, T., 1993. IPF1, a homeodomain-
containing transactivator of the insulin gene. EMBO J. 12, 4251–4259.
Offield, M.F., Jetton, T.L., Labosky, P.A., Ray, M., Stein, R.W., Magnuson,
M.A., Hogan, B.L., Wright, C.V., 1996. PDX-1 is required for pancreatic
outgrowth and differentiation of the rostral duodenum. Development 122,
983–995.
Panin, V.M., Papayannopoulos, V., Wilson, R., Irvine, K.D., 1997. Fringe
modulates Notch–ligand interactions. Nature 387, 908–912.
Pedersen, A.a.H., R.S., 2005. A possible role for the canonical Wnt pathway in
endocrine cell development in chicks.Romm, E., Nielsen, J.A., Kim, J.G., Hudson, L.D., 2005. Myt1 family recruits
histone deacetylase to regulate neural transcription. J. Neurochem. 93,
1444–1453.
Sander, M., German, M.S., 1997. The beta cell transcription factors and
development of the pancreas. J. Mol. Med. 75, 327–340.
Sander, M., Sussel, L., Conners, J., Scheel, D., Kalamaras, J., Dela Cruz, F.,
Schwitzgebel, V., Hayes-Jordan, A., German, M., 2000. Homeobox gene
Nkx6.1 lies downstream of Nkx2.2 in the major pathway of beta-cell
formation in the pancreas. Development 127, 5533–5540.
Schwitzgebel, V.M., Scheel, D.W., Conners, J.R., Kalamaras, J., Lee, J.E.,
Anderson, D.J., Sussel, L., Johnson, J.D., German, M.S., 2000. Expression
of neurogenin3 reveals an islet cell precursor population in the pancreas.
Development 127, 3533–3542.
Shimizu, K., Chiba, S., Saito, T., Kumano, K., Takahashi, T., Hirai, H., 2001.
Manic fringe and lunatic fringe modify different sites of the Notch2
extracellular region, resulting in different signaling modulation. J. Biol.
Chem. 276, 25753–25758.
Slack, J.M., 1995. Developmental biology of the pancreas. Development 121,
1569–1580.
Sosa-Pineda, B., Chowdhury, K., Torres, M., Oliver, G., Gruss, P., 1997. The
Pax4 gene is essential for differentiation of insulin-producing beta cells in
the mammalian pancreas. Nature 386, 399–402.
Stern, C.D., 2005. The chick; a great model system becomes even greater. Dev.
Cell 8, 9–17.
St-Onge, L., Sosa-Pineda, B., Chowdhury, K., Mansouri, A., Gruss, P., 1997.
Pax6 is required for differentiation of glucagon-producing alpha-cells in
mouse pancreas. Nature 387, 406–409.
St-Onge, L., Wehr, R., Gruss, P., 1999. Pancreas development and diabetes.
Curr. Opin. Genet. Dev. 9, 295–300.
Sussel, L., Kalamaras, J., Hartigan-O'Connor, D.J., Meneses, J.J., Pedersen,
R.A., Rubenstein, J.L., German, M.S., 1998. Mice lacking the home-
odomain transcription factor Nkx2.2 have diabetes due to arrested
differentiation of pancreatic beta cells. Development 125, 2213–2221.
Tanabe, Y., William, C., Jessell, T.M., 1998. Specification of motor neuron
identity by the MNR2 homeodomain protein. Cell 95, 67–80.
Vasiliauskas, D., Laufer, E., Stern, C.D., 2003. A role for hairy1 in regulating
chick limb bud growth. Dev. Biol. 262, 94–106.
Wierup, N., Svensson, H., Mulder, H., Sundler, F., 2002. The ghrelin cell: a
novel developmentally regulated islet cell in the human pancreas. Regul.
Pept. 107, 63–69.
Wilson, M.E., Scheel, D., German, M.S., 2003. Gene expression cascades in
pancreatic development. Mech. Dev. 120, 65–80.
Yang, L.T., Nichols, J.T., Yao, C., Manilay, J.O., Robey, E.A., Weinmaster, G.,
2005. Fringe glycosyltransferases differentially modulate Notch1 proteol-
ysis induced by Delta1 and Jagged1. Mol. Biol. Cell 16, 927–942.
Zhang, N., Norton, C.R., Gridley, T., 2002. Segmentation defects of Notch
pathway mutants and absence of a synergistic phenotype in lunatic fringe/
radical fringe double mutant mice. Genesis 33, 21–28.
